Abbott Laboratories/ US0028241000 /
11/12/2024 9:49:22 PM | Chg. -0.03 | Volume | Bid9:49:22 PM | Ask9:49:22 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
116.77USD | -0.02% | 2.06 mill. Turnover: 167.54 mill. |
116.77Bid Size: 800 | 116.79Ask Size: 800 | 202.61 bill.USD | 1.78% | 35.61 |
Assets
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 5,905 | 5,935 | 5,730 | 5,705 | 7,607 | ||||||
Intangible Assets | 5,735 | 6,198 | 5,562 | 4,539 | 21,473 | ||||||
Long-Term Investments | 119 | 229 | 4,041 | 2,947 | 883 | ||||||
Fixed Assets | - | 26,014 | 27,092 | 25,890 | 56,103 | ||||||
Inventories | 2,693 | 2,643 | 2,599 | 2,434 | 3,601 | ||||||
Accounts Receivable | 3,986 | 3,586 | 3,418 | 3,248 | 5,249 | ||||||
Cash and Cash Equivalents | 3,475 | 4,063 | 5,001 | 18,620 | 9,407 | ||||||
Current Assets | 19,247 | 15,261 | 14,155 | 26,776 | 20,147 | ||||||
Total Assets | 42,953 | 41,275 | 41,247 | 52,666 | 76,250 |
Liabilities
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1,026 | 1,064 | 1,081 | 1,178 | 2,402 | ||||||
Long-term debt | - | 3,408 | 5,871 | 20,681 | 27,210 | ||||||
Liabilities to Banks | 3,164 | 4,382 | 3,127 | 1,322 | 206 | ||||||
Provisions | 175 | 270 | 430 | 188 | 309 | ||||||
Liabilities | 17,686 | 19,636 | 19,921 | 31,949 | 45,152 | ||||||
Share Capital | - | 12,383 | 12,734 | 13,027 | 23,206 | ||||||
Total Equity | 25,267 | 21,639 | 21,326 | 20,717 | 31,098 | ||||||
Minority Interests | 96 | 113 | 115 | 179 | 201 | ||||||
Total liabilities equity | 42,953 | 41,275 | 41,247 | 52,666 | 76,250 |
Income Statement
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 21,848 | 20,247 | 20,405 | 20,853 | 27,390 | ||||||
Depreciation (total) | 791 | 1,548 | 1,472 | 1,353 | 3,021 | ||||||
Operating Result | 2,629 | 2,599 | 2,867 | 3,185 | 1,726 | ||||||
Interest Income | -90 | -73 | -58 | -332 | -780 | ||||||
Income Before Taxes | 2,521 | 2,518 | 3,183 | 1,413 | 2,231 | ||||||
Income Taxes | 138 | 797 | 577 | 350 | 1,878 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 2,576 | 2,284 | 4,423 | 1,400 | 477 |
Per Share
Cash Flow
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 3,324 | 3,675 | 2,966 | 3,203 | 5,570 | ||||||
Cash Flow from Investing Activities | -3,929 | -202 | 406 | -248 | -9,618 | ||||||
Cash Flow from Financing | -6,696 | -2,742 | -2,236 | 11,147 | -5,281 | ||||||
Decrease / Increase in Cash | -7,327 | 588 | 938 | 13,619 | -9,213 | ||||||
Employees | 69,000 | 77,000 | 74,000 | 75,000 | 99,000 |